----
Current ValuationThe current P/E ratio is 59.19, within the reasonable range, cheaper than 34.2% of the time in the past 5 years, and the industry ranks 118/223, the industry Median 22.04.
59.19xP/E
¥11.65Stock price
¥0.20Earnings per share
59.19xP/E
Stock price¥11.65Earnings per share¥0.20
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 41.45x
- Typical range
- -30.91x–74.42x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 22.04x
015304560
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 22.04x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
600436SHZZPZH | 58.91x | 4.02% | ¥77.58B |
002653SZHaisco | 47.98x | 597.96% | ¥62.54B |
002821SZAsymchem | 41.13x | 16.58% | ¥48.72B |
300765SZCSPC Innovation | 45.77x | 628.47% | ¥45.44B |
002294SZSalubris | 46.60x | 29.31% | ¥33.32B |
300199SZHYBIO | 48.05x | -- | ¥19.31B |
301569SZNOVAST | 52.20x | -- | ¥16.24B |
603858SHBUCHANG PHARMA | 56.69x | -- | ¥15.98B |
002755SZASK PHARM | 59.19x | -- | ¥10.81B |
002626SZKingdomway | 45.84x | 56.36% | ¥10.67B |
300725SZPHARMABLOCK | 47.28x | 18.18% | ¥10.47B |
600851SHHX GROUP | 52.52x | -- | ¥10.03B |
300049SZFurui Co.,Ltd. | 56.59x | 75.86% | ¥9.96B |
600789SHLKPC | 52.22x | -- | ¥7.12B |
688553SHHUIYU PHARMACEUTICAL | 50.83x | -- | ¥6.57B |
688799SHHWPC | 54.18x | 24.46% | ¥6.17B |
002390SZxinbang phar. | 43.12x | -- | ¥5.97B |
301393SZHighfine | 46.88x | -- | ¥5.78B |
002907SZPharscin Pharma | 58.79x | -- | ¥5.52B |
301281SZKeyuan Pharma | 57.89x | -- | ¥4.08B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
